Quick Answer
Coya Therapeutics, Inc. reported Shares Outstanding of 20.93 million shares for fiscal year 2025.
Coya Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 20.93M | +25.3% |
| 2024 | 16.71M | +16.0% |
| 2023 | 14.41M | +456.1% |
| 2022 | 2.59M | +0.0% |
| 2021 | 2.59M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 16.74M | +10.0% | +0.1% |
| June 30, 2025 | 16.72M | +9.9% | +0.0% |
| March 31, 2025 | 16.72M | +14.5% | +0.1% |
| December 31, 2024 | 16.71M | +16.0% | +9.8% |
| September 30, 2024 | 15.22M | +53.0% | +0.0% |
| June 30, 2024 | 15.22M | +53.0% | +4.2% |
| March 31, 2024 | 14.61M | +46.9% | +1.4% |
| December 31, 2023 | 14.41M | +456.1% | +44.8% |
- Coya Therapeutics, Inc. showed an increase of +25.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Coya Therapeutics, Inc.’s shares outstanding has grown by 708.3% (from 2.59 million shares to 20.93 million shares).
- The most recent figure is from Coya Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: